Retriever Medical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Retriever Medical is a pre-revenue, clinical-stage medical device company targeting the venous thrombectomy market with its ClotHound™ system. The device is engineered to mechanically engage and remove acute, sub-acute, and chronic wall-adherent thrombus while providing distal embolic protection, a key differentiator. The company is advancing the system through preclinical validation with a regulatory pathway targeting 510(k) clearance for DVT, and the platform has potential future applications in pulmonary embolism and complex venous thrombosis. Founded in 2016, the company is headquartered in San Jose, California.

Cardiovascular

Technology Platform

Dual-sphere mechanical thrombectomy system with integrated distal embolic protection, designed to engage and remove acute, sub-acute, and chronic wall-adherent venous thrombus.

Opportunities

The large and growing market for venous thrombectomy, combined with the specific unmet need for treating sub-acute and chronic wall-adherent clot, presents a significant addressable opportunity.

Successful demonstration of efficacy and safety could position ClotHound™ as a preferred tool for complex cases.

The platform's potential expansion into pulmonary embolism offers a pathway to an even larger market.

Risk Factors

Key risks include the failure of preclinical results to translate to human clinical safety and efficacy, regulatory delays or setbacks in the 510(k) process, and intense competition from both established medtech companies and well-funded startups in the thrombectomy space.

Competitive Landscape

The venous thrombectomy market is competitive, featuring large players like Boston Scientific, Medtronic, and Philips, as well as specialized rivals such as Inari Medical, Penumbra, and newer entrants. Retriever's differentiation hinges on its specific design for chronic clot and built-in embolic protection.

More companies in Drug Delivery & Formulation →More companies in United States →